Placenta has a long history of use for treating burns and wounds. It is a rich source of collagen and other extracellular matrix proteins, tissue reparative growth factors, and stem cells, including mesenchymal stem cells (MSCs). Recent data show its therapeutic potential for orthopaedic sports medicine indications.
Purpose:
To provide orthopaedic surgeons with an anatomic description of the placenta, to characterize its cellular composition, and to review the literature reporting the use of placenta-derived cells and placental tissue allografts for orthopaedic sports medicine indications in animal models and in humans.
Study Design:
Systematic review.
Methods:
Using a total of 63 keyword combinations, the PubMed and MEDLINE databases were searched for published articles describing the use of placental cells and/or tissue for orthopaedic sports medicine indications. Information was collected on placental tissue type, indications, animal model, study design, treatment regimen, safety, and efficacy outcomes. Results were categorized by indication and subcategorized by animal model.
Results:
Outcomes for 29 animal studies and 6 human studies reporting the use of placenta-derived therapeutics were generally positive; however, the placental tissue source, clinical indication, and administration route were highly variable across these studies. Fourteen animal studies described the use of placental tissue for tendon injuries, 13 studies for osteoarthritis or articular cartilage injuries, 3 for ligament injuries, and 1 for synovitis. Both placenta-derived culture-expanded cells (epithelial cells or MSCs) and placental tissue allografts were used in animal studies. In all human studies, commercial placental allografts were used. Five of 6 human studies examined the treatment of foot and ankle pathological conditions, and 1 studied the treatment of knee osteoarthritis.
Conclusion:
A review of the small number of reported studies revealed a high degree of variability in placental cell types, placental tissue preparation, routes of administration, and treatment regimens, which prohibits making any definitive conclusions. Currently, the clinical use of placenta is limited to only commercial placental tissue allografts, as there are no placenta-derived biological drugs approved for the treatment of orthopaedic sports medicine conditions in the United States. However, this review shows that the application of placental cells or tissue allografts appears to be safe and has potential to improve outcomes for orthopaedic sports medicine indications.
AntoniadouEDavidAL. Placental stem cells. Best Pract Res Clin Obstet Gynaecol. 2015;31:13-29.
2.
BailoMSonciniMVertuaEet al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004;78(10):1439.
3.
BakshDYaoRTuanRS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25(6):1384-1392.
4.
BarboniBRussoVCuriniVet al. Achilles tendon regeneration can be improved by amniotic epithelial cell allotransplantation. Cell Transplant. 2012;21(11):2377-2395.
5.
BarlowSBrookeGChatterjeeKet al. Comparison of human placenta- and bone marrow–derived multipotent mesenchymal stem cells. Stem Cells Dev. 2008;17(6):1095-1108.
6.
BiebackKBrinkmannI. Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J Stem Cells. 2010;2(4):81-92.
7.
BrantleyJNVerlaTD. Use of placental membranes for the treatment of chronic diabetic foot ulcers. Adv Wound Care (New Rochelle). 2015;4(9):545-559.
8.
CapelliCGottiEMorigiMet al. Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy. 2011;13(7):786-801.
9.
CaplanAI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007;213(2):341-347.
10.
CaplanAI. What’s in a name?Tissue Eng Part A. 2010;16(8):2415-2417.
11.
ChungJ-YSongMHaC-WKimJ-ALeeC-HParkY-B. Comparison of articular cartilage repair with different hydrogel-human umbilical cord blood-derived mesenchymal stem cell composites in a rat model. Stem Cell Res Ther. 2014;5(2):39.
12.
CobanISatoğluISGültekinATunaBTatariHFidanM. Effects of human amniotic fluid and membrane in the treatment of Achilles tendon ruptures in locally corticosteroid-induced Achilles tendinosis: an experimental study on rats. Foot Ankle Surg. 2009;15(1):22-27.
13.
CovasDTSiufiJLCSilvaARLOrellanaMD. Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res. 2003;36(9):1179-1183.
14.
De BariCDell’AccioFTylzanowskiPLuytenFP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Care Res. 2001;44(8):1928-1942.
DemirkanFColakogluNHerekOErkulaG. The use of amniotic membrane in flexor tendon repair: an experimental model. Arch Orthop Trauma Surg. 2002;122(7):396-399.
17.
DominiciMLe BlancKMuellerIet al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
FriedensteinAJChailakhjanRKLalykinaKS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393-403.
20.
GarciaDLongoUGVaqueroJet al. Amniotic membrane transplant for articular cartilage repair: an experimental study in sheep. Curr Stem Cell Res Ther. 2015;10(1):77-83.
21.
Gholizadeh-GhalehazizSFarahzadiRFathiEPashaiaslM. A mini overview of isolation, characterization and application of amniotic fluid stem cells. Int J Stem Cells. 2015;8(2):115-120.
22.
GonzalezPLCarvajalCCuencaJet al. Chorion mesenchymal stem cells show superior differentiation, immunosuppressive, and angiogenic potentials in comparison with haploidentical maternal placental cells. Stem Cells Transl Med. 2015;4(10):1109-1121.
23.
HaC-WParkY-BChungJ-YParkY-G. Cartilage repair using composites of human umbilical cord blood-derived mesenchymal stem cells and hyaluronic acid hydrogel in a minipig model. Stem Cells Transl Med. 2015;4(9):1044-1051.
24.
HanselmanAETidwellJESantrockRD. Cryopreserved human amniotic membrane injection for plantar fasciitis: a randomized, controlled, double-blind pilot study. Foot Ankle Int. 2015;36(2):151-158.
25.
IguraKZhangXTakahashiKMitsuruAYamaguchiSTakahashiTA. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy. 2004;6(6):543-553.
26.
IlancheranSMoodleyYManuelpillaiU. Human fetal membranes: a source of stem cells for tissue regeneration and repair?Placenta. 2009;30(1):2-10.
27.
JangK-MLimHCJungWYMoonSWWangJH. Efficacy and safety of human umbilical cord blood-derived mesenchymal stem cells in anterior cruciate ligament reconstruction of a rabbit model: new strategy to enhance tendon graft healing. Arthroscopy. 2015;31(8):1530-1539.
28.
JinCZParkSRChoiBHLeeK-YKangCKMinB-H. Human amniotic membrane as a delivery matrix for articular cartilage repair. Tissue Eng. 2007;13(4):693-702.
29.
KavianiAPerryTEDzakovicAJenningsRWZieglerMMFauzaDO. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001;36(11):1662-1665.
30.
KernSEichlerHStoeveJKlüterHBiebackK. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294-1301.
31.
KimJ-KKimT-HParkS-Wet al. Protective effects of human placenta extract on cartilage degradation in experimental osteoarthritis. Biol Pharm Bull. 2010;33(6):1004-1010.
32.
KueckelhausMPhilipJKamelRAet al. Sustained release of amnion-derived cellular cytokine solution facilitates achilles tendon healing in rats. Eplasty. 2014;14:e29.
33.
la Fuente DeAMateosJLesende-RodríguezIet al. Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells. Mol Cell Proteomics. 2012;11(2):M111.010496.
34.
Lange-ConsiglioARossiDTassanSPeregoRCremonesiFParoliniO. Conditioned medium from horse amniotic membrane-derived multipotent progenitor cells: immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo. Stem Cells Dev. 2013;22(22):3015-3024.
35.
Lange-ConsiglioATassanSCorradettiBet al. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries. Cytotherapy. 2013;15(8):1011-1020.
36.
LeeOKKuoTKChenW-MLeeK-DHsiehS-LChenT-H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 2004;103(5):1669-1675.
37.
LiCDZhangWYLiH-Let al. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation. Cell Res. 2005;15(7):539-547.
38.
LiFChenY-ZMiaoZ-NZhengS-YJinJ. Human placenta-derived mesenchymal stem cells with silk fibroin biomaterial in the repair of articular cartilage defects. Cell Reprogram. 2012;14(4):334-341.
39.
LiuPFGuoLZhaoDWZhangZJKangK. Study of human acellular amniotic membrane loading bone marrow mesenchymal stem cells in repair of articular cartilage defect in rabbits. Genet Mol Res. 2014;13(3):7992-8001.
40.
LulloveE. A flowable placental tissue matrix allograft in lower extremity injuries: a pilot study. Cureus. 2015;7(6):e275.
41.
MajoreIMorettiPStahlFHassRKasperC. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev. 2011;7(1):17-31.
42.
MarmottiAMattiaSBruzzoneMet al. Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study. Stem Cells Int. 2012;2012:326813.
43.
MuttiniAMattioliMPetrizziLet al. Experimental study on allografts of amniotic epithelial cells in calcaneal tendon lesions of sheep. Vet Res Commun. 2010;34 Suppl 1(S1):S117-S120.
44.
MuttiniARussoVRossiEet al. Pilot experimental study on amniotic epithelial mesenchymal cell transplantation in natural occurring tendinopathy in horses: ultrasonographic and histological comparison. Muscles Ligaments Tendons J. 2015;5(1):5-11.
45.
MuttiniAValbonettiLAbateMet al. Ovine amniotic epithelial cells: in vitro characterization and transplantation into equine superficial digital flexor tendon spontaneous defects. Res Vet Sci. 2013;94(1):158-169.
46.
NogamiMKimuraTSekiSet al. A human amnion-derived extracellular matrix-coated cell-free scaffold for cartilage repair: in vitro and in vivo studies. Tissue Eng Part A. 2016;22(7-8):680-688.
47.
OzbolukSOzkanYOztürkAGülNOzdemirRMYanikK. The effects of human amniotic membrane and periosteal autograft on tendon healing: experimental study in rabbits. J Hand Surg Eur Vol. 2010;35(4):262-268.
48.
OzgenelGY. The effects of a combination of hyaluronic and amniotic membrane on the formation of peritendinous adhesions after flexor tendon surgery in chickens. J Bone Joint Surg Br. 2004;86(2):301-307.
49.
OzgenelGYSamliBOzcanM. Effects of human amniotic fluid on peritendinous adhesion formation and tendon healing after flexor tendon surgery in rabbits. J Hand Surg Am. 2001;26(2):332-339.
50.
PappaKIAnagnouNP. Novel sources of fetal stem cells: where do they fit on the developmental continuum?Regen Med. 2009;4(3):423-433.
51.
ParkG-YKwonDRLeeSC. Regeneration of full-thickness rotator cuff tendon tear after ultrasound-guided injection with umbilical cord blood-derived mesenchymal stem cells in a rabbit model. Stem Cells Transl Med. 2015;4(11):1344-1351.
52.
ParkSKohS-EHurCYLeeW-DLimJLeeY-J. Comparison of human first and third trimester placental mesenchymal stem cell. Cell Biol Int. 2013;37(3):242-249.
53.
ParkY-BSongMLeeC-HKimJ-AHaC-W. Cartilage repair by human umbilical cord blood-derived mesenchymal stem cells with different hydrogels in a rat model. J Orthop Res. 2015;33(11):1580-1586.
54.
ParoliniOAlvianoFBagnaraGPet al. Concise review: isolation and characterization of cells from human term placenta. Outcome of the First International Workshop on Placenta Derived Stem Cells. Stem Cells. 2008;26(2):300-311.
PoloniAMauriziGSerraniFet al. Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate. Cell Prolif. 2012;45(1):66-75.
57.
PrasannaSJGopalakrishnanDShankarSRVasandanAB. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One. 2010;5(2):e9016.
58.
RibohJCSaltzmanBMYankeABColeBJ. Human amniotic membrane-derived products in sports medicine: basic science, early results, and potential clinical applications. Am J Sports Med. 2016;44(9):2425-2434.
SarugaserRLickorishDBakshDHosseiniMMDaviesJE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005;23(2):220-229.
61.
SaulnierNViguierEPerrier-GroultEet al. Intra-articular administration of xenogeneic neonatal mesenchymal stromal cells early after meniscal injury down-regulates metalloproteinase gene expression in synovium and prevents cartilage degradation in a rabbit model of osteoarthritis. Osteoarthritis Cartilage. 2015;23(1):122-133.
62.
SessaregoNParodiAPodestàMet al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica. 2008;93(3):339-346.
63.
SonciniMVertuaEGibelliLet al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med. 2007;1(4):296-305.
64.
SternM. The grafting of preserved amniotic membrane to burned and ulcerated surfaces, substituting skin grafts: a preliminary report. J Am Med Assoc. 1913;60(13):973.
65.
SungHJHongSCYooJHet al. Stemness evaluation of mesenchymal stem cells from placentas according to developmental stage: comparison to those from adult bone marrow. J Korean Med Sci. 2010;25(10):1418-1426.
66.
TodaAOkabeMYoshidaTNikaidoT. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci. 2007;105(3):215-228.
67.
TroyerDLWeissML. Concise review: Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008;26(3):591-599.
68.
UnderwoodMAGilbertWMShermanMP. Amniotic fluid: not just fetal urine anymore. J Perinatol. 2005;25(5):341-348.
69.
VangsnessCTFarrJBoydJDellaeroDTMillsCRLeRoux-WilliamsM. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014;96(2):90-98.
70.
VangsnessCTSternbergHHarrisL. Umbilical cord tissue offers the greatest number of harvestable mesenchymal stem cells for research and clinical application: a literature review of different harvest sites. Arthroscopy. 2015;31(9):1836-1843.
71.
VinesJBAliprantisAOGomollAHFarrJ. Cryopreserved amniotic suspension for the treatment of knee osteoarthritis. J Knee Surg. 2016;29(6):443-450.
72.
WangHSHungS-CPengSTet al. Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells. 2004;22(7):1330-1337.
73.
WarnerMLasyoneL. An open-label, single-center, retrospective study of cryopreserved amniotic membrane and umbilical cord tissue as an adjunct for foot and ankle surgery. Surg Technol Int. 2014;25:251-255.
74.
WeiJPNawataMWakitaniSet al. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning Stem Cells. 2009;11(1):19-26.
75.
WeissMLMedicettySBledsoeARet al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson’s disease. Stem Cells. 2006;24(3):781-792.
76.
WerberB. Amniotic tissues for the treatment of chronic plantar fasciosis and achilles tendinosis. J Sports Med. 2015;2015(1):1-6.
77.
WillettNJThoteTLinASPet al. Intra-articular injection of micronized dehydrated human amnion/chorion membrane attenuates osteoarthritis development. Arthritis Res Ther. 2014;16(1):R47.
78.
WilliamsLBKoenigJBBlackBGibsonTWGSharifSKochTG. Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an LPS induced synovitis model. Equine Vet J. 2016;48(5):619-625.
79.
YanHYuC. Repair of full-thickness cartilage defects with cells of different origin in a rabbit model. Arthroscopy. 2007;23(2):178-187.
80.
YaoBHuangSGaoDXieJLiuNFuX. Age-associated changes in regenerative capabilities of mesenchymal stem cell: impact on chronic wounds repair. Int Wound J. 2016;13(6):1252-1259.
81.
ZelenCMPokaAAndrewsJ. Prospective, randomized, blinded, comparative study of injectable micronized dehydrated amniotic/chorionic membrane allograft for plantar fasciitis: a feasibility study. Foot Ankle Int. 2013;34(10):1332-1339.
82.
ZukPAZhuMAshjianPet al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279-4295.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
